|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases expression |
ISO |
KRN 7000 results in increased expression of CXCL10 protein |
CTD |
PMID:15867097 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Il12b |
interleukin 12B |
increases expression |
ISO |
KRN 7000 results in increased expression of IL12B protein |
CTD |
PMID:15867097 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
|
G |
Gata3 |
GATA binding protein 3 |
multiple interactions |
ISO |
[Ovalbumin co-treated with alpha-galactosylceramide] results in decreased expression of GATA3 mRNA |
CTD |
PMID:30803854 |
|
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
[Floxacillin co-treated with alpha-galactosylceramide] results in increased expression of GPT protein |
CTD |
PMID:30993380 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Ifng |
interferon gamma |
multiple interactions increases secretion |
ISO |
[Alcohols co-treated with alpha-galactosylceramide] results in increased expression of IFNG protein; [Ovalbumin co-treated with alpha-galactosylceramide] results in increased secretion of IFNG protein alpha-galactosylceramide results in increased secretion of IFNG protein |
CTD |
PMID:12482940 PMID:25499027 PMID:30803854 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
[Ovalbumin co-treated with alpha-galactosylceramide] results in decreased secretion of IL10 protein |
CTD |
PMID:30803854 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO |
[Ovalbumin co-treated with alpha-galactosylceramide] results in decreased secretion of IL13 protein |
CTD |
PMID:30803854 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
[Ovalbumin co-treated with alpha-galactosylceramide] results in decreased secretion of IL17A protein |
CTD |
PMID:30803854 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il4 |
interleukin 4 |
increases secretion multiple interactions |
ISO |
alpha-galactosylceramide results in increased secretion of IL4 protein [Ovalbumin co-treated with alpha-galactosylceramide] results in decreased secretion of IL4 protein |
CTD |
PMID:12482940 PMID:30803854 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
multiple interactions |
ISO |
[Ovalbumin co-treated with alpha-galactosylceramide] results in decreased secretion of IL5 protein |
CTD |
PMID:30803854 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Klrb1b |
killer cell lectin like receptor B1B |
decreases expression |
ISO |
alpha-galactosylceramide results in decreased expression of KLRB1C protein |
CTD |
PMID:30993380 |
|
NCBI chr 4:161,948,259...161,961,537
Ensembl chr 4:161,890,577...161,961,675
|
|
G |
Rorc |
RAR-related orphan receptor C |
multiple interactions |
ISO |
[Ovalbumin co-treated with alpha-galactosylceramide] results in decreased expression of RORC mRNA alternative form |
CTD |
PMID:30803854 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
G |
Tbx21 |
T-box transcription factor 21 |
multiple interactions |
ISO |
[Ovalbumin co-treated with alpha-galactosylceramide] results in increased expression of TBX21 mRNA |
CTD |
PMID:30803854 |
|
NCBI chr10:82,082,322...82,098,831
Ensembl chr10:82,082,322...82,098,831
|
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
affects localization multiple interactions |
ISO |
phytosphingosine affects the localization of AIFM1 protein 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [phytosphingosine affects the localization of AIFM1 protein] |
CTD |
PMID:15486061 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions affects localization increases expression |
ISO |
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased localization of BAX protein]; [arsenic trioxide co-treated with phytosphingosine] results in increased localization of BAX protein; Acetylcysteine inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased localization of BAX protein]; SB 203580 inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased localization of BAX protein] phytosphingosine affects the localization of BAX protein phytosphingosine results in increased expression of BAX protein |
CTD |
PMID:15486061 PMID:17237268 PMID:36334778 PMID:37956922 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression |
ISO |
phytosphingosine results in increased expression of BCL2 protein |
CTD |
PMID:36334778 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression |
ISO |
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of CASP3 protein]; [Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of CASP3 protein; phytosphingosine results in increased expression of and results in increased cleavage of CASP3 protein; SB 203580 inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of CASP3 protein] phytosphingosine results in increased expression of CASP3 protein |
CTD |
PMID:17237268 PMID:36334778 PMID:37956922 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression |
ISO |
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein]; [arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein; SB 203580 inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein] phytosphingosine results in increased expression of CASP9 protein |
CTD |
PMID:17237268 PMID:37956922 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
phytosphingosine results in decreased expression of CCNB1 protein |
CTD |
PMID:37956922 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
phytosphingosine results in decreased expression of CDK1 protein |
CTD |
PMID:37956922 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression |
ISO |
phytosphingosine results in increased expression of CYCS protein |
CTD |
PMID:36334778 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
[arsenic trioxide co-treated with phytosphingosine] results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:17237268 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased phosphorylation of MAPK14 protein]; [arsenic trioxide co-treated with phytosphingosine] results in increased phosphorylation of MAPK14 protein; Acetylcysteine inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:17237268 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
[arsenic trioxide co-treated with phytosphingosine] results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:17237268 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases activity increases cleavage |
ISO |
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein]; [Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein; [Arsenic Trioxide co-treated with phytosphingosine] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein] phytosphingosine results in increased activity of PARP1 protein phytosphingosine results in increased cleavage of PARP1 protein |
CTD |
PMID:15486061 PMID:17237268 PMID:37956922 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pink1 |
PTEN induced kinase 1 |
decreases expression |
ISO |
phytosphingosine results in decreased expression of PINK1 protein |
CTD |
PMID:36334778 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|